Small and Rural
The Subcommittee’s initiative aims to identify opportunities to reduce legislative and regulatory burdens on Medicare providers, thus improving the efficiency and quality of the Medicare program for seniors and individuals with disabilities.
The panel that advises the Centers for Medicare & Medicaid Services on hospital outpatient payments sent a clear signal to the agency this week: Don’t shortchange patients’ access to vital pharmaceuticals by cutting the 340B Drug Pricing Program. CMS’s Advisory Panel on Hospital Outpatient…
As urged by the AHA and others, a Centers for Medicare & Medicaid Services advisory panel today recommended that the agency not finalize for 2018 a proposal that would drastically cut Medicare payments for drugs acquired under the 340B Drug Pricing Program. In July, CMS proposed to pay…
The Health Resources and Services Administration has provided an update on its new 340B Office of Pharmacy Affairs Information System, which includes a new registration system and a new secure pricing system. HRSA said the registration component of the new 340B OPAIS will be released in mid-…
The Health Resources and Services Administration today proposed delaying until July 1, 2018 the effective date of its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers. The final rule has been subject to multiple delays since January, and most…
CMS releases FY 2018 inpatient PPS final rule
The Centers for Medicare & Medicaid Services yesterday issued final fiscal year 2018 rules for the hospital inpatient prospective payment system and long-term care hospital PPS.
The Centers for Medicare & Medicaid Services (CMS) August 2 issued its hospital inpatient prospective payment system (PPS) and long-term care hospital (LTCH) PPS final rule for fiscal year (FY) 2018. Select highlights of the final rule related to the inpatient PPS follow.